Plant Name: Peperomia pellucida
Taxonomic Information:
Plant ID: NPO13657
Plant Latin Name: Peperomia pellucida
Taxonomy Genus: Peperomia
Taxonomy Family: Piperaceae
Plant External Links:
NCBI TaxonomyDB:
352190
Plant-of-the-World-Online:
679378-1
Used in Medicines:
Country/Region:
Brazil; Thailand; Nigeria; IndonesiaTraditional Medicine System:
Geographical Distribution:
Brazil; Bangladesh; Kenya; Sudan; Guinea; Costa Rica; Cambodia; Malawi; Ethiopia; Somalia; Peru; Nigeria; Bolivia; Cameroon; Cote d'Ivoire; Benin; Ghana; Cuba; Venezuela; Zambia; Burkina Faso; Togo; Zimbabwe; China; Thailand; Dominican Republic; Belize; Sierra Leone; Liberia; Netherlands; Uganda; Oman; Tanzania; Indonesia; Trinidad and Tobago; Gabon; Guinea-Bissau; Guyana; Honduras; Haiti; Jamaica; Seychelles; Angola; Suriname; Mexico; India; Senegal; Congo; Mozambique; Colombia; Burundi; French Guiana; Taiwan; Fiji; Comoros
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Collective Molecular Activities of the Plant
List of Human Proteins Collectively Targeted by the Plant
Click Gene ID to Access Activity Profile of Individual Target
| TSHR; | |
| ESR1; | |
| LMNA; |
List of Human Cytochrome P450 Enzymes Affected by the Plant
Click Gene ID to Access Activity Profile of Individual Enzyme
Detailed Information of Target Proteins
| Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|
| Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
| Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
| Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
| Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
| Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Enrichment of Gene Ontology of Target Proteins (Activity≤10μM)
Detailed Information of Enriched Gene Ontolgy
| GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
|---|---|---|---|---|---|
| BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 8.038E-07 | 1.750E-02 | CYP1A2, CYP2C19 |
| BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.410E-06 | 2.565E-02 | CYP1A2, CYP2C19 |
| BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 3.534E-06 | 2.565E-02 | CYP1A2, CYP2C19 |
| BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.124E-05 | 6.116E-02 | CYP1A2, CYP2C19 |
| BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.027E-05 | 8.827E-02 | CYP1A2, CYP2C19, ESR1 |
| MF | GO:0005488; binding | GO:0019825; oxygen binding | 5.283E-05 | 1.917E-01 | CYP1A2, CYP2C19 |
| MF | GO:0003824; catalytic activity | GO:0004497; monooxygenase activity | 2.371E-04 | 3.813E-01 | CYP1A2, CYP2C19 |
| MF | GO:0005488; binding | GO:0020037; heme binding | 4.301E-04 | 4.026E-01 | CYP1A2, CYP2C19 |
| MF | GO:0060089; molecular transducer activity | GO:0004996; thyroid-stimulating hormone receptor activity | 5.177E-04 | 4.026E-01 | TSHR |
| MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 5.177E-04 | 4.026E-01 | ESR1 |
| MF | GO:0003824; catalytic activity | GO:0016705; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 6.297E-04 | 4.569E-01 | CYP1A2, CYP2C19 |
| MF | GO:0005488; binding | GO:0005506; iron ion binding | 6.708E-04 | 4.569E-01 | CYP1A2, CYP2C19 |
| CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 2.063E-02 | 1.000E+00 | CYP1A2, CYP2C19 |
| CC | GO:0016020; membrane | GO:0031090; organelle membrane | 2.225E-02 | 1.000E+00 | CYP1A2, CYP2C19, LMNA |
| CC | GO:0044464; cell part | GO:0005635; nuclear envelope | 4.149E-02 | 1.000E+00 | LMNA |
Enriched KEGG Pathways of Target Proteins (Activity≤10μM)
Top 10 KEGG Pathways (ordered by adjusted p-value)
Detailed Information of Enriched KEGG Pathways
| Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
|---|---|---|---|---|---|---|
| 09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.025E-05 | 5.062E-04 | CYP1A2, CYP2C19 |
| 09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.165E-04 | 1.373E-03 | CYP1A2, CYP2C19 |
| 09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.647E-04 | 1.373E-03 | CYP1A2, CYP2C19 |
| 09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 9.961E-03 | 3.061E-02 | CYP1A2 |
| 09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.442E-02 | 3.061E-02 | CYP1A2 |
| 09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.615E-02 | 3.061E-02 | CYP1A2 |
| 09150 Organismal Systems | 09152 Endocrine system | hsa04918 | Thyroid hormone synthesis | 1.763E-02 | 3.061E-02 | TSHR |
| 09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.812E-02 | 3.061E-02 | CYP1A2 |
| 09160 Human Diseases | 09165 Cardiovascular diseases | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 1.837E-02 | 3.061E-02 | LMNA |
| 09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.250E-03 | 7.809E-03 | CYP1A2 |
Human Diseases Associated with the Target Proteins of the Plant
Detailed Information of Human Diseases
| ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
|---|
>> Profiles of ingredients and activity landscape
>> Targets derived from weak experimental activities
